AVITA Medical Inc (ASX:AVH)
A$ 2.51 -0.18 (-6.69%) Market Cap: 326.18 Mil Enterprise Value: 312.88 Mil PE Ratio: 0 PB Ratio: 9.47 GF Score: 72/100

AVITA Medical Inc Investor Webinar Transcript

Sep 20, 2022 / 10:30PM GMT
Release Date Price: A$1.74 (-2.79%)
Rudi Michelson;Monsoon Communications;Consultant

Good afternoon to everyone in U.S., and good morning to those joining us from Australia. I'm Rudi Michelson of Monsoon Communications. Welcome and thank you for joining us for AVITA's Investor Webinar.

This time it happens to follow the company's compelling pivotal top line results for RECELL and stable vitiligo last week. The efficacy was strong and a further endorsement of the RECELL technology and its commercial potential. Now let me point out that you can submit questions using the Q&A function and we'll get to them after the presentation. Presenting today is AVITA's CEO, Dr. Mike Perry; and CFO, Michael Holder.

I'll now hand over to Mike to begin the presentation.

Michael S. Perry
AVITA Medical, Inc. - CEO, President & Executive Director

Thanks again. Thank you, Rudi, for the introduction, and welcome, everybody. Good morning, good afternoon, depending upon where you are.

Next slide, please. As we are publicly traded, there was a disclosure

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot